# Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

> **NCT00117767** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 720 (—)

## Conditions studied

- Tinea Capitis

## Interventions

- **DRUG:** Terbinafine hydrochloride (HCl)
- **DRUG:** Griseofulvin

## Key facts

- **NCT ID:** NCT00117767
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-03
- **Final completion:** —
- **Target enrollment:** 720 (—)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117767, "Terbinafine Compared to Griseofulvin in Children With Tinea Capitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00117767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*